Executive Summary -
From Data Collection to Decision-Making in Clinical Trials
Clinical trials are generating unprecedented volumes of data, yet translating that data into timely, confident decisions remains a persistent challenge.
This executive summary captures insights from the 2026 SCOPE Roundtable, examining how protocol design, real-time visibility, AI governance, and stronger system integration can help close the gap between data capture and operational clarity.
More Content
Read more related content below
Article: The Quiet Shift Reshaping Metabolic Trial Execution
As metabolic trials evolve beyond short-term weight loss, sponsors are rethinking how nutrition and lifestyle support fit into execution models. Explore why participation burden, cultural context, and specialist clinician roles are becoming increasingly relevant — and what it takes to integrate them at scale.
Article: The Operational Shift Redefining Clinical Trial Execution
As trials become more demanding to run, long-standing assumptions about site capacity, patient participation, and data oversight are being tested. This article looks beyond innovation headlines to examine the practical pressures shaping how studies are executed — and why the mechanics of participation and data capture are now influencing trial outcomes as much as protocol design.
Webinar: Community First: How Local Engagement Builds Better Clinical Trials
Clinical trials often struggle to reach diverse patient populations due to distance, access, and trust barriers. Learn how community-first research models help expand access, reduce patient burden, and improve enrollment and retention through local engagement.
Executive Summary: Rethinking Trial Access Through Trust-Driven Design and Local Collaboration
Clinical research is evolving to meet patients where they are. This discussion recap explores how sponsors and site leaders are strengthening community engagement, designing trials around real-world patient needs, and building trust to expand participation and retention in underrepresented populations.
Case Study: Expanding Accessibility in a Phase 3 Influenza Study Through Community-Based Research
This case study highlights how a community-based research model improved accessibility and patient retention in a global Phase 3 influenza vaccine trial. By leveraging localized sites and mobile visits, this approach strengthened engagement, reduced patient dropout, and delivered more representative trial outcomes - helping the industry advance research that reflects real-world populations.
Video: Transforming clinical trial accessibility with EmVenio
With just 5% of the US population participating in clinical trials, reducing barriers and improving patient optionality is vital for broader accessibility and improved patient outcomes. EmVenio is transforming clinical research, moving beyond traditional sites and into communities to make trials more accessible to patients, without compromising oversight or data integrity.
Infographic: From Ideas To Implementation: Navigating Operational Challenges In Community Research
Gain strategic insights from a survey of hundreds of clinical research leaders on the benefits and challenges in community-based models. From barriers to implementation, to shaping future trial designs and the therapeutic areas poised for expansion - this infographic reveals where the industry is headed.
Research Report: Evaluating The Role Of Community-Based Models In Trial Design
Community-based trials are growing, with 56% of organizations now adopting models. By addressing operational complexities and regulatory challenges, the industry can take advantage of their full potential. Citeline and EmVenio surveyed 130 senior clinical operations leaders on where community-based research is adding value and their perspectives on future integration.
Roundtable Summary: Community Connections: Leveraging Localized Patient Access in Clinical Trials For Better Representation, Improved Retention and Higher Quality Data
Discover how community based approaches are revolutionizing patient recruitment and retention - driving higher data quality, improving trial efficiency and strengthening regulatory compliance - and why investing early is a game changer for trial success.
Whitepaper: The power of choice: Why patient optionality is the key to advancing clinical research Entering a new era of research
As clinical trials move beyond traditional brick-and-mortar sites, decentralized and hybrid trial models are transforming the clinical research landscape, enabling greater patient representation. Explore how hybrid trial designs and community based approaches are improving patient recruitment and retention, especially among underrepresented groups.
Inspire. Connect. Innovate.
